---
title: "DexCom, Inc. (DXCM.US) — Company Overview"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/DXCM.US/overview.md"
symbol: "DXCM.US"
name: "DexCom, Inc."
parent: "https://longbridge.com/en/quote/DXCM.US.md"
datetime: "2026-04-04T21:26:26.364Z"
locales:
  - [en](https://longbridge.com/en/quote/DXCM.US/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DXCM.US/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DXCM.US/overview.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/DXCM.US/overview.md) | [繁體中文](https://longbridge.com/zh-HK/quote/DXCM.US/overview.md)


# DexCom, Inc. (DXCM.US) — Company Overview

## Basic Information

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Address | 6340 Sequence Drive, San Diego, California, United States |
| Website | [www.dexcom.com](https://www.dexcom.com) |

## Company Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

## Key Executives

| Name | Title |
|------|-------|
| Kevin Ronald Sayer | Executive Chairman of the Board |
| Jacob Steven Leach | President, CEO & Director |
| Jereme M. Sylvain | Executive VP, CFO & Chief Accounting Officer |
| Michael Jon Brown | Executive VP & Chief Legal Officer |
| Sadie M. Stern | Executive VP & Chief Human Resources Officer |
| Nicholas Augustinos | Independent Director |
| Mark G. Foletta | Lead Independent Director |
| Bridgette P. Heller | Independent Director |

## Major Shareholders

| Name | Ratio | Report Date |
|------|-------|-------------|
| The Vanguard Group, Inc. | 12.75% | 2025-12-31 |
| BlackRock, Inc. | 10.35% | 2025-12-31 |
| State Street Global Advisors, Inc. | 4.70% | 2025-12-31 |
| Baillie Gifford & Co. | 4.04% | 2025-12-31 |
| Geode Capital Management, LLC | 2.86% | 2025-12-31 |
| UBS Asset Management AG | 2.58% | 2025-12-31 |
| AllianceBernstein L.P. | 2.24% | 2025-12-31 |
| Norges Bank Investment Management | 1.89% | 2025-12-31 |
| Jennison Associates LLC | 1.50% | 2025-12-31 |
| JP Morgan Asset Management | 1.31% | 2025-12-31 |

## Business Breakdown

| Segment | Revenue | Ratio |
|---------|---------|-------|
| Patient Monitoring Equipment | 4662000000 | 100% |

```vega-lite
{
  "$schema": "https://vega.github.io/schema/vega-lite/v5.json",
  "title": "DexCom, Inc. Business Breakdown",
  "data": {
    "values": [
      {
        "segment": "Patient Monitoring Equipment",
        "ratio": 100
      }
    ]
  },
  "mark": "arc",
  "encoding": {
    "theta": {
      "field": "ratio",
      "type": "quantitative"
    },
    "color": {
      "field": "segment",
      "type": "nominal"
    }
  }
}
```

## Geographic Segments

| Region | Revenue | Ratio |
|--------|---------|-------|
| United States (U.S.) | 3334900000 | 71.53% |
| International | 1327100000 | 28.47% |


---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**